ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) logo

ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) Employee Directory

Pharmaceutical ManufacturingCalifornia, United States51-200 Employees

ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) has about 167 employees across 4 continents, most of them in North America. By country, the largest groups are United States Of America (59%), Turkey (12%) and Morocco (5%). Sales and Biotechnology make up over half of the profiles with a known department. ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)'s workforce spans 5 departments.

Find ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) employees' phone numbers or email addresses

ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) Global Highlights

Location
Employees

North America
127

Minus sign iconPlus sign icon
  • United States Of America
    125
  • Costa Rica
    1
  • El Salvador
    1

Asia
45

Minus sign iconPlus sign icon
  • Turkey
    26
  • India
    8
  • Philippines
    2
  • China
    2
  • Israel
    2
  • Malaysia
    2
  • Pakistan
    1
  • Russian Federation
    1
  • Bangladesh
    1

Africa
19

Minus sign iconPlus sign icon
  • Morocco
    10
  • Tunisia
    3
  • Tanzania
    2
  • Angola
    1
  • Algeria
    1
  • Madagascar
    1
  • Nigeria
    1

Europe
19

Minus sign iconPlus sign icon
  • France
    6
  • Portugal
    3
  • Italy
    3
  • Germany
    3
  • Sweden
    1
  • United Kingdom Of Great Britain And Northern Ireland
    1
  • Ireland
    1
  • Spain
    1

South America
2

Minus sign iconPlus sign icon
  • Colombia
    2

Oceania
1

Minus sign iconPlus sign icon
  • Australia
    1

North America accounts for 60% of ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)'s workforce, followed by Asia (21%) and Africa (9%).

ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)'s Leadership

  • Head Of Business Intelligence, Salesforce Effectivness & Commercial Operations at ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
    K. M.
    Head Of Business Intelligence, Salesforce Effectivness & Commercial Operations
  • Owner at ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
    S. S.
    Owner
  • Medical Affairs Director, Surgical, Emea at ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
    A. W.
    Medical Affairs Director, Surgical, Emea
  • Surgical Manager Africa at ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
    K. C.
    Surgical Manager Africa
  • General Manager at ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
    D. K.
    General Manager
  • EMEA Business Development Manager Cosmetics / Aesthetics / Surgical at ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
    S. V.
    EMEA Business Development Manager Cosmetics / Aesthetics / Surgical
  • Sr. Systems Analyst, Logistics & Distribution Systems at ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
    M. C.
    Sr. Systems Analyst, Logistics & Distribution Systems
  • Senior Programmer Analyst at ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
    P. C.
    Senior Programmer Analyst

ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) Employee Metrics

100%
50%
0%
2026
2025
  • Sales
  • Biotechnology
  • Administrative
  • Business
  • Education
  • Other
  • Healthcare Services

Sales is the largest department at 63% of profiles with a known department, followed by Biotechnology (16%) and Administrative (11%).

Contact profiles from ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)

Name
Title
Contact
Location
Last Update
  • Owner at ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
    S. S.
    Owner
    India, Tamil Nadu
    Jun 02, 2026
  • Head Of Business Intelligence, Salesforce Effectivness & Commercial Operations at ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
    K. M.
    Head Of Business Intelligence, Salesforce Effectivness & Commercial Operations
    Germany, Schleswig-Holstein
    Sep 29, 2026
  • Medical Affairs Director, Surgical, Emea at ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
    A. W.
    Medical Affairs Director, Surgical, Emea
    France, Occitanie
    Apr 14, 2026
  • Surgical Manager Africa at ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
    K. C.
    Surgical Manager Africa
    Tunisia
    Jun 02, 2026
  • General Manager at ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
    D. K.
    General Manager
    India, Telangana
    Feb 01, 2024
  • EMEA Business Development Manager Cosmetics / Aesthetics / Surgical at ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
    S. V.
    EMEA Business Development Manager Cosmetics / Aesthetics / Surgical
    France, Auvergne-Rhône-Alpes
    Jul 28, 2023
  • Sr. Systems Analyst, Logistics & Distribution Systems at ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
    M. C.
    Sr. Systems Analyst, Logistics & Distribution Systems
    Oct 19, 2026
  • Senior Programmer Analyst at ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
    P. C.
    Senior Programmer Analyst
    Oct 23, 2024
  • Staff Accountant at ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
    S. S.
    Staff Accountant
    Australia, New South Wales
    Feb 02, 2024
  • Validierungsmanager at ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
    J. W.
    Validierungsmanager
    Germany, Bavaria
    Feb 01, 2024

Frequently Asked Questions

What are the largest departments at ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)?

Minus sign iconPlus sign icon
Sales is the largest department at 63% of profiles with a known department, followed by Biotechnology (16%) and Administrative (11%). ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)'s workforce spans 5 departments.

Where are ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)'s employees located?

Minus sign iconPlus sign icon
ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) has about 167 employees across 4 continents, most of them in North America. North America accounts for 60% of ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)'s workforce, followed by Asia (21%) and Africa (9%). By country, the largest groups are United States Of America (59%), Turkey (12%) and Morocco (5%).

How many employees does ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) have currently?

Minus sign iconPlus sign icon
ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) has approximately 167 employees as of October 2026. These team members are located across 6 continents, including North America, Asia and Africa.

Who are ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)'s key employees and leadership?

Minus sign iconPlus sign icon

As of October 2026, ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)'s key employees include:

  • Head Of Business Intelligence, Salesforce Effectivness & Commercial Operations: K. M.
  • Owner: S. S.
  • Medical Affairs Director, Surgical, Emea: A. W.
  • Surgical Manager Africa: K. C.
  • General Manager: D. K.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

What is ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)'s most common email format?

Minus sign iconPlus sign icon
ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) employees' email format typically follows the pattern of First.Last@bausch.com. Trying to find reliable and up-to-date employee contact data? Find more ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) email formats with LeadIQ.

What is ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) known for?

Minus sign iconPlus sign icon
ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) was founded in 2000 and operates in the Pharmaceutical Manufacturing industry. Explore ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)'s company overview page for more information.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.